Expected viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19

B Joob, V Wiwanitkit - Clinical and Applied Thrombosis …, 2021 - journals.sagepub.com
COVID-19 vaccine is the hope for containment of disease outbreak. The post vaccination
adverse effect is an important consideration. The clot after vaccination is an emerging …

[HTML][HTML] Blood viscosity of COVID-19 patient: a preliminary report

B Joob, V Wiwanitkit - American journal of blood research, 2021 - ncbi.nlm.nih.gov
COVID-19 is the important global problem. This new coronavirus can cause several
hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19 …

Changes in the blood viscosity in patients with SARS-CoV-2 infection

HM Al-Kuraishy, AI Al-Gareeb, SM Al-Hamash… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

COVID-19-Associated Hyperviscosity: A Potential Link between Inflammation and Thrombophilia

C Maier, AD Truong, S Auld, D Polly… - Available at SSRN …, 2020 - papers.ssrn.com
Although COVID-19 begins as a respiratory pneumonia, we are now discovering it causes
an intense inflammatory response accompanied by systemic microangiopathy. In reflecting …

Dengue after COVID-19 vaccination: possible and might be missed

A Kebayoon, V Wiwanitkit - Clinical and Applied Thrombosis …, 2021 - journals.sagepub.com
Dear Editor, COVID-19 vaccination is recommended as a primary prevention of COVID-19.
Data on safety and adverse effect of the new COVID-19 vaccine is very important. Of several …

Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness

R Mungmunpuntipantip… - Clinical and Applied …, 2021 - journals.sagepub.com
Dear Editor, we would like to share ideas on the publication “Effects of Thrombocytopenia
and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination.” 1 Haimei noted that …

COVID-19 vaccine-related thrombosis: a systematic review and exploratory analysis

C Bilotta, G Perrone, V Adelfio, GF Spatola… - Frontiers in …, 2021 - frontiersin.org
Introduction The World Health Organization declared the coronavirus disease 2019 (COVID-
19) pandemic on March 11, 2020. Two vaccine types were developed using two different …

Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination

S Yamada, H Asakura - International Journal of Molecular Sciences, 2022 - mdpi.com
Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …

A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration

V D'Agostino, F Caranci, A Negro, V Piscitelli… - Journal of personalized …, 2021 - mdpi.com
Globally, at the time of writing (20 March 2021), 121.759. 109 confirmed COVID-19 cases
have been reported to the WHO, including 2.690. 731 deaths. Globally, on 18 March 2021, a …

An update on the pathogenesis of COVID-19 and the reportedly rare thrombotic events following vaccination

B Kantarcioglu, O Iqbal, JM Walenga… - Clinical and Applied …, 2021 - journals.sagepub.com
Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem. After more …